Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam for anxiety in pediatric epilepsy
NCT03371836Phase 4Completed
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger
- Start
- Oct 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clobazam in anxiety disorder, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger. Started Oct 2017; status: completed.
02
Drugs
clobazam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03371836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371836.